Page 11 of 13

PA17.1 | Aplastic Anemia & Bone Marrow Failure — Graded Quiz

Graded 12 questions · Untimed · 2 attempts

Click any question card to reveal the correct answer.

Q1 PA17.1 1 pt

A 17-year-old girl presents with 6 weeks of progressive fatigue, gum bleeding, and two episodes of epistaxis. She has no lymphadenopathy or organomegaly. CBC: Hb 5.8 g/dL (normocytic), WBC 1.8 × 10⁹/L (neutrophils 0.3 × 10⁹/L), platelets 9 × 10⁹/L, reticulocyte count 0.4%. A bone marrow trephine biopsy is reported as: '10% cellularity with fat replacement; no blasts; no fibrosis; no malignant cells.' Which single criterion in this report is most critical for classifying this as 'very severe aplastic anaemia' (vsAA) rather than 'severe aplastic anaemia' (SAA)?

A Absolute neutrophil count (ANC) below 0.2 × 10⁹/L, which is the defining threshold separating vsAA from SAA
B Marrow cellularity below 15%, which defines vsAA and distinguishes it from the 25% threshold used for SAA
C Platelet count below 10 × 10⁹/L, which upgrades the severity classification from SAA to vsAA
D Haemoglobin below 6 g/dL with reticulocyte count below 1%, which defines the erythroid criterion for vsAA

Click to reveal answer

Q2 PA17.1 1 pt

A 14-year-old boy is evaluated for aplastic anaemia. His physical examination reveals short stature (below 3rd percentile), several café-au-lait spots, and the right thumb appears hypoplastic. A chromosome breakage test using diepoxybutane (DEB) shows significantly increased chromosomal breaks compared to controls. His sister (age 18) has a normal CBC and normal DEB test. Which statement about this patient's condition is most accurate?

A Fanconi anaemia is confirmed; his sister's normal DEB test confirms she is not a carrier, so family HLA typing is not indicated
B Fanconi anaemia is confirmed; despite the sister's normal CBC, she may still be an HLA-matched carrier and could be a stem cell donor
C The DEB result confirms Diamond-Blackfan anaemia, which requires different management from aplastic anaemia
D Fanconi anaemia is confirmed; allogeneic HSCT is contraindicated because Fanconi cells cannot tolerate conditioning chemotherapy

Click to reveal answer

Q3 PA17.1 1 pt

A 55-year-old man presents with pancytopenia (Hb 7.2 g/dL, WBC 2.1 × 10⁹/L, platelets 34 × 10⁹/L). He was treated for seronegative hepatitis 3 months ago and remains non-icteric. Bone marrow biopsy: 15% cellularity, predominantly fat cells, markedly reduced trilineage haematopoiesis, no blasts, no dysplastic changes, no fibrosis. Which statement best describes the pathogenesis of aplastic anaemia in this clinical context?

A Viral hepatitis directly destroys haematopoietic stem cells through hepatotropic viral proteins that have cross-reactivity with HSC surface antigens
B CD8+ cytotoxic T lymphocytes activated by unknown antigen exposure destroy haematopoietic stem cells via Fas–FasL interaction and IFN-γ/TNF-α-mediated apoptosis
C Autoantibodies generated during hepatitis target glycophorin A on erythroid precursors, causing selective erythroid aplasia with secondary neutropenia and thrombocytopenia
D Hepatic iron overload from seronegative hepatitis causes haemosiderotic marrow damage, replacing haematopoietic cells with iron deposits

Click to reveal answer

Q4 PA17.1 1 pt

A 23-year-old woman with severe aplastic anaemia (SAA) has no HLA-matched sibling. She receives horse anti-thymocyte globulin (hATG) plus cyclosporine as first-line immunosuppressive therapy. At 6-month follow-up, her CBC shows: Hb 9.1 g/dL, WBC 3.2 × 10⁹/L (neutrophils 1.4 × 10⁹/L), platelets 54 × 10⁹/L. She is no longer transfusion-dependent. However, flow cytometry shows a GPI-anchor-deficient clone comprising 12% of her granulocytes. What is the most accurate interpretation of this finding?

A Development of paroxysmal nocturnal haemoglobinuria (PNH) clone is a recognised late complication/evolution of aplastic anaemia after immunosuppressive therapy, requiring clinical monitoring but not immediate treatment at 12% clone size
B The PNH clone of 12% indicates clonal haematopoiesis of indeterminate potential (CHIP) and predicts imminent transformation to acute myeloid leukaemia
C A GPI-negative clone of 12% after ATG confirms that the original diagnosis was PNH presenting as aplastic anaemia, not true aplastic anaemia
D The PNH clone is a treatment effect of cyclosporine causing acquired PIG-A mutations in previously normal haematopoietic progenitors

Click to reveal answer

Q5 PA17.1 1 pt

A 65-year-old man presents with pancytopenia: Hb 8.4 g/dL, MCV 98 fL, WBC 2.6 × 10⁹/L, platelets 42 × 10⁹/L. Physical examination shows NO hepatosplenomegaly and NO lymphadenopathy. Bone marrow aspirate shows hypercellular fragments with dysplastic erythroid precursors, hypersegmented neutrophils, and hypolobate megakaryocytes. Marrow blasts are 4%. Which diagnosis is most consistent with this picture?

A Aplastic anaemia — the hypercellular fragments on aspirate indicate a sampling error from the trephine biopsy
B Myelodysplastic syndrome (MDS) — pancytopenia with dysmorphic, hypercellular marrow and <20% blasts
C Megaloblastic anaemia from vitamin B12 deficiency — dysmorphic precursors and pancytopenia are explained by impaired DNA synthesis
D Acute myeloid leukaemia (AML) — blast percentage of 4% is the diagnostic threshold, and dysplastic changes confirm myeloid origin

Click to reveal answer

Q6 PA17.1 1 pt

A 30-year-old female nurse presents with a 3-month history of easy bruising and recurrent upper respiratory infections. CBC: Hb 9.3 g/dL, MCV 88 fL, WBC 2.0 × 10⁹/L (neutrophils 0.6 × 10⁹/L), platelets 28 × 10⁹/L. She reports handling chloramphenicol eye drops regularly at work. Bone marrow biopsy: 20% cellularity with marked fat replacement, no dysplasia, no fibrosis, no blasts. She has NO history of relevant family disease, congenital anomalies, or prior chemotherapy. Which management step is MOST urgent at this moment?

A Start high-dose systemic corticosteroids immediately to suppress immune-mediated marrow destruction pending HLA typing
B Remove her from chloramphenicol exposure and initiate protective isolation with empirical broad-spectrum antibiotics given ANC of 0.6 × 10⁹/L
C Remove her from chloramphenicol exposure urgently and initiate supportive care (transfusions, infection prophylaxis) while arranging HLA typing and haematology referral
D Start antifungal prophylaxis and schedule elective bone marrow transplantation after identifying a matched unrelated donor over the next 3 months

Click to reveal answer

Q7 PA17.1 1 pt

A bone marrow biopsy is reported from a 40-year-old man with pancytopenia. The pathologist describes: 'Marrow cellularity 8%; haematopoietic cells constitute less than 10% of the marrow space; remainder is fat; no fibrosis; no blasts; no abnormal infiltrate. Residual haematopoietic cells include lymphocytes and plasma cells.' How should the marrow cellularity estimate be interpreted in relation to this patient's age?

A Normal for age — marrow cellularity naturally decreases to 8% by age 40, so the biopsy does not confirm aplastic anaemia
B Profoundly hypocellular — expected cellularity for a 40-year-old is approximately 60%, making 8% far below normal and consistent with aplastic anaemia
C Borderline hypocellular — the 25% cellularity threshold for aplastic anaemia means 8% falls within the normal age-adjusted range
D The absolute cellularity is irrelevant; only the residual cell types (lymphocytes and plasma cells) determine whether this represents aplastic anaemia or lymphoma

Click to reveal answer

Q8 PA17.1 1 pt

A 25-year-old man with severe aplastic anaemia (SAA) has an HLA-matched sibling identified. The haematologist plans allogeneic haematopoietic stem cell transplantation (allo-HSCT) as definitive therapy. The family asks why HSCT is preferred over long-term immunosuppressive therapy (IST) in a young patient with a matched donor. Which explanation is most scientifically accurate?

A HSCT replaces the defective immune and haematopoietic system with a new donor-derived system, offering a higher chance of durable cure with no relapse risk compared to IST in young patients with a matched sibling
B IST is toxic and causes more immediate mortality than HSCT; therefore HSCT is always safer and preferred for all age groups
C HSCT eliminates the need for blood transfusions immediately; IST requires lifelong transfusion support even after haematologic response
D HSCT is the only treatment that eliminates the risk of clonal evolution to AML; IST has no effect on leukaemic transformation risk

Click to reveal answer

Q9 PA17.1 1 pt

During a bone marrow aspiration procedure for a patient with suspected AA, the clinician withdraws the needle into the syringe and finds the aspirate contains only peripheral blood with no marrow spicules or particles — a 'dry tap.' Which is the most appropriate immediate next step?

A Repeat the aspiration at a different angle from the same needle entry site before abandoning the procedure
B Abandon aspiration and proceed with a trephine biopsy from the same or contralateral posterior superior iliac crest, as dry tap indicates a condition requiring histological (not cytological) assessment
C Request an emergency peripheral blood smear and reticulocyte count as substitutes for the bone marrow aspirate
D Attempt sternal aspiration immediately as the posterior iliac crest is an unreliable site for aspiration in adults

Click to reveal answer

Q10 PA17.1 1 pt

A 10-year-old boy presents with recurrent anaemia, short stature, and hypopigmented macules on the trunk. His parents are consanguineous. CBC shows pancytopenia. Karyotype shows an increased frequency of chromatid exchanges in cultured lymphocytes after mitomycin C (MMC) treatment. His older brother (12 years) is healthy, with a normal MMC chromosomal stress test. Which statement regarding the brother as a potential donor for allogeneic HSCT is most accurate?

A The brother is confirmed to NOT be a carrier because his MMC test is normal; he can be considered as a matched donor based solely on HLA typing
B The MMC test confirms the brother does not have Fanconi anaemia, but he may be a heterozygous carrier; HLA typing is still required before donor suitability is confirmed
C Fanconi anaemia is autosomal dominant, so the brother has a 50% chance of being affected; a normal MMC test in a carrier is unreliable
D The brother should NOT be used as a donor because carrier cells donated to a patient with Fanconi anaemia would perpetuate the same chromosomal fragility in the transplanted marrow

Click to reveal answer

Q11 PA17.1 1 pt

A 50-year-old woman with newly diagnosed aplastic anaemia has no HLA-matched sibling. Her absolute neutrophil count is 0.42 × 10⁹/L (not very severe AA). She is not a candidate for matched unrelated donor HSCT due to comorbidities. Horse anti-thymocyte globulin (hATG) + cyclosporine is planned. Which statement accurately predicts her expected haematologic response trajectory?

A Complete response (transfusion independence, near-normal counts) typically occurs within 1–2 weeks of completing the hATG course
B Approximately 60–70% of patients achieve a haematologic response by 3–6 months; non-responders at 6 months should be considered for a second ATG course or MUD-HSCT if eligible
C Response to hATG is all-or-none; if the patient does not achieve a complete response by 3 months, she will almost certainly not respond and should proceed to immediate allogeneic HSCT
D Cyclosporine has no additive benefit over hATG alone; it is added solely to prevent ATG-associated serum sickness and can be stopped after 6 weeks

Click to reveal answer

Q12 PA17.1 1 pt

A 19-year-old female college student presents with 6 weeks of pallor, easy bruising, and recurrent mouth ulcers. She was previously healthy and takes no medications. There is NO hepatosplenomegaly and NO lymphadenopathy. CBC: Hb 7.6 g/dL (normocytic), WBC 2.3 × 10⁹/L (ANC 0.45 × 10⁹/L), platelets 18 × 10⁹/L, reticulocyte count 0.3%. Bone marrow trephine: 12% cellularity, predominantly fat, markedly reduced trilineage haematopoiesis, no dysplasia, no blasts, no fibrosis. Which laboratory result would MOST strongly support an immune-mediated (T-cell-driven) pathogenesis in this patient and guide treatment selection?

A Elevated serum IFN-γ and TNF-α levels with an increased CD8+/CD4+ ratio and expanded oligoclonal CD8+ T-cell populations in peripheral blood
B Elevated serum ferritin and transferrin saturation indicating iron overload as the primary cause of marrow suppression
C Positive antinuclear antibody (ANA) titre confirming this as a manifestation of systemic lupus erythematosus
D Increased chromosomal fragility on mitomycin C stress test identifying Fanconi anaemia as the underlying diagnosis requiring tailored HSCT conditioning

Click to reveal answer